Clinical Trial Update: Metformin in Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing metformin in chronic kidney disease with cardiovascular/metabolic syndrome comorbidity; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Metabolic Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Chronic Kidney Disease, Cardiovascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-11-04